1998 FDA Approved Drugs

The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results. Review descriptions for our medical therapeutic area list to help assist in your search.

Join our Drug Research Updates group on LinkedIn! 
Find out more about the types of drugs included in this listing.

Cardiology/Vascular Diseases

Agrylin (anagrelide HCL); Roberts Pharmaceutical; Treatment for Thrombocythemia, Approved December 1998

CellCept; Roche; Treatment for the prevention of organ rejection inpatients undergoing heart transplants, Approved February 1998

Diovan HCT (valsartan); Novartis; Treatment for hypertension, Approved March 1998

Integrilin; COR Therapeutics, Key Pharmaceuticals; Injection of eptifibatide, Approved May 1998

Micardis (telmisartan); Boehringer Ingelheim; Treatment for Hypertension, Approved November 1998

Rythmol; Knoll Pharmaceutical; Treatment for paroxysmal atrial fibrillation, Approved January 1998

Tiazac (diltiazem hydrochloride); Forest Laboratories; Treatment for chronic stable angina, Approved February 1998

Tricor (fenofibrate); Abbott Laboratories; Treatment for very high triglyceride levels, Approved February 1998

Viagra; Pfizer; Treatment for impotence, Approved March 1998

Dental and Oral Health

Atridox; Atrix Laboratories; Treatment for periodontal disease, Approved September 1998

Periostat (doxycycline hyclate); CollaGenex Pharmaceuticals; Treatment for periodontitis., Approved October 1998

Dermatology

Dynabac; Sanofi-aventis; Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections), Approved March 1998

Lustra; Medicis Pharmaceutical; Treatment for ultraviolet-induced skin discolorations, Approved January 1998

MetroLotion; Galderma Laboratories; Treatment of inflammatory papules and pustules of rosacea, Approved November 1998

Noritate; Dermik Laboratories; Treatment for rosacea, Approved January 1998

Salagen Tablets; MGI Pharma; Treatment for Sjogren's Syndrome, Approved February 1998

Sulfamylon; Mylan Laboratories; Treatment used to control bacterial infections on excised burn wounds, Approved June 1998

Thalomid; Celgene; Treatment for moderate to severe erythema nodosum leprosum (ENL), Approved July 1998

Endocrinology

Actonel; Procter & Gamble, Hoechst Marion Roussel; Treatment for Paget's Disease, Approved April 1998

Arava; Hoechst Marion Roussel; Treatment for Rheumatoid Arthritis, Approved September 1998

Celexa; Forest Laboratories; Treatment for depression, Approved July 1998

CellCept; Roche; Treatment for the prevention of organ rejection inpatients undergoing heart transplants, Approved February 1998

Clomipramine hydrochloride; Mylan Laboratories; Generic equivalent of Anafranil, Approved April 1998

Diovan HCT (valsartan); Novartis; Treatment for hypertension, Approved March 1998

Esclim; Fournier Research; Treatment for symptoms associated to Menopause, Approved August 1998

Estratab (.3 mg ); Solvay Pharmaceuticals; Treatment for the prevention of osteoporosis, Approved March 1998

Glucagon; Eli Lilly; Treatment for severe hypoglycemia associated with diabetes., Approved October 1998

Glucagon; Eli Lilly; Treatment for severe Hypoglycemia, Approved September 1998

Glyburide Tablets; Mylan Laboratories; Treatment for Diabetes Mellitus (Type II), Approved July 1998.

Herceptin; Genentech; Treatment for metastatic breast cancer, Approved October 1998

Inform HER-2/neu breast cancer test; Oncor; Treatment for breast cancer prediction, Approved January 1998

Marplan Tablets; Roche; Treatment of Depression, Approved August 1998

Mircette; Organon; Oral contraceptive, Approved April 1998

Prempro; Wyeth; Treatment for hormone replacement therapy, Approved January 1998

Prometrium; Schering-Plough; Treatment for Endometrial Hyperplasia, Approved December 1998

Proscar; Merck; Treatment for complication relating to benign prostatic hyperplasia (BPH), Approved April 1998

Simulect; Novartis; Treatment for acute organ transplant rejection, Approved May 1998

Xeloda; Roche; Treatment for advanced breast cancer tumors, Approved April 1998

Zemplar; Abbott Laboratories; Treatment of secondary hyperparathyroidism associated with chronic renal failure, Approved April 1998

Family Medicine

Amerge; GlaxoSmithKline; Treatment for acute migraine, Approved February 1998

Arava; Hoechst Marion Roussel; Treatment for Rheumatoid Arthritis, Approved September 1998

Celexa; Forest Laboratories; Treatment for depression, Approved July 1998

Cimetidine Hydrochloride Oral Solution; Pharmaceutical Formulations; Generic equivalent of Tagamet HB 200, Approved June 1998

Clomipramine hydrochloride; Mylan Laboratories; Generic equivalent of Anafranil, Approved April 1998

Clonazepam; Watson Pharmaceuticals; Generic equivalent of Klonopin, Approved January 1998

Cosopt; Merck; Treatment for glaucoma or ocular hypertension, Approved April 1998

Diovan HCT (valsartan); Novartis; Treatment for hypertension, Approved March 1998

Esclim; Fournier Research; Treatment for symptoms associated to Menopause, Approved August 1998

Estratab (.3 mg ); Solvay Pharmaceuticals; Treatment for the prevention of osteoporosis, Approved March 1998

Etodolac; Faulding; Generic equivalent of Lodine 500 mg tablets, Approved May 1998

Excedrin Migraine; Bristol-Myers Squibb; Treatment for mild to moderate migraine pain, Approved January 1998

Gemzar (gemcitabine HCL); Eli Lilly; Treatment for Lung Cancer, Approved August 1998

Glucagon; Eli Lilly; Treatment for severe hypoglycemia associated with diabetes., Approved October 1998

Glyburide Tablets; Mylan Laboratories; Treatment for Diabetes Mellitus (Type II), Approved July 1998.

Herceptin; Genentech; Treatment for metastatic breast cancer, Approved October 1998

Inform HER-2/neu breast cancer test; Oncor; Treatment for breast cancer prediction, Approved January 1998

Lamictal Chewable Dispersible Tablets; GlaxoSmithKline; Treatment for Epilepsy, Approved August 1998

Lodine XL (etodolac); Wyeth; Treatment for arthritis, Approved February 1998

Lovenox (enoxaparin sodium) Injection; Rhone Poulenc Rorer; Treatment for prevention of blood clots following hip-replacement surgery, Approved February 1998

Marplan Tablets; Roche; Treatment of Depression, Approved August 1998

Maxalt; Merck; Acute treatment of migraine headache, Approved June 1998

Naltrexone Hydrochloride Tablets; Barr Laboratories; Generic equivalent of Revia, Approved May 1998

Noritate; Dermik Laboratories; Treatment for rosacea, Approved January 1998

Photofrin; QLT; Treatment for early-stage, microinvasive endobronchial non-small cell lung cancer, Approved January 1998

Prempro; Wyeth; Treatment for hormone replacement therapy, Approved January 1998

PREVACID(R) (lansopraxole); TAP Pharmaceuticals; Treatment of heartburn associated with GERD, Approved April 1998

Prilosec (omeprazole); Astra Merck; Treatment for heartburn, Approved January 1998

Proleukin; Chiron; Treatment for metastatic melanoma, Approved January 1998

Prometrium; Solvay Pharmaceuticals; Treatment for amenorrhea (abnormal cessation of menses), Approved May 1998

Rocephin; Roche; Treatment for pediatric otitis media, Approved January 1998

Singulair; Merck; Treatment for asthma, Approved February 1998

Sulfamylon; Mylan Laboratories; Treatment used to control bacterial infections on excised burn wounds, Approved June 1998

Synagis; MedImmune; Treatment for the prevention of serious lower respiratory tract disease in infants, Approved June 1998

Tasmar; Roche; Treatment for Parkinson's Disease, Approved January 1998

Tiazac (diltiazem hydrochloride); Forest Laboratories; Treatment for chronic stable angina, Approved February 1998

Viagra; Pfizer; Treatment for impotence, Approved March 1998

Vitravene Injection; Isis Pharmaceuticals; Treatment for CMV in AIDS patients, Approved August 1998

Xeloda; Roche; Treatment for advanced breast cancer tumors, Approved April 1998

Zantac 75 Efferdose; GlaxoSmithKline; Treatment for heartburn, Approved March 1998

Gastroenterology

Cimetidine Hydrochloride Oral Solution; Pharmaceutical Formulations; Generic equivalent of Tagamet HB 200, Approved June 1998

PREVACID(R) (lansopraxole); TAP Pharmaceuticals; Treatment of heartburn associated with GERD, Approved April 1998

Prilosec (omeprazole); Astra Merck; Treatment for heartburn, Approved January 1998

Zantac 75 Efferdose; GlaxoSmithKline; Treatment for heartburn, Approved March 1998

Genetic Disease

Clonazepam; Watson Pharmaceuticals; Generic equivalent of Klonopin, Approved January 1998

Lamictal Chewable Dispersible Tablets; GlaxoSmithKline; Treatment for Epilepsy, Approved August 1998

Pulmozyme (dornase alfa); Genentech; Treatment for cystic fibrosis, Approved March 1998

Hematology

Actonel; Procter & Gamble, Hoechst Marion Roussel; Treatment for Paget's Disease, Approved April 1998

Droxia; Bristol-Myers Squibb; Treatment for sickle-cell anemia, Approved March 1998

Glucagon; Eli Lilly; Treatment for severe Hypoglycemia, Approved September 1998

Lovenox (enoxaparin sodium) Injection; Rhone Poulenc Rorer; Treatment for prevention of blood clots following hip-replacement surgery, Approved February 1998

Neupogen; Amgen; Treatment for slow white blood cell recovery following chemotherapy, Approval April 1998

Refludan; Hoechst Marion Roussel; Treatment of heparin-induced thrombocytopenia type II, Approved March 1998

Hepatology (Liver, Pancreatic, Gall Bladder)

Pulmozyme (dornase alfa); Genentech; Treatment for cystic fibrosis, Approved March 1998

REBETRON (TM) Combination Therapy; Schering-Plough; Treatment for Chronic Hepatitis C, Approved June 1998

Immunology

Allegra-D; Hoechst Marion Roussel; Treatment for nasal congestion due to seasonal allergy, Approved March 1998

CellCept; Roche; Treatment for the prevention of organ rejection inpatients undergoing heart transplants, Approved February 1998

Clemastine fumarate syrup; Morton Grove Pharmaceuticals; Generic equivalent of Tavist Syrup, Approved March 1998

Cleocin (clindamycin phosphate); Pharmacia & Upjohn; Treatment for bacterial vaginosis, Approved March 1998

Dynabac; Sanofi-aventis; Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections), Approved March 1998

REBETRON (TM) Combination Therapy; Schering-Plough; Treatment for Chronic Hepatitis C, Approved June 1998

Simulect; Novartis; Treatment for acute organ transplant rejection, Approved May 1998

Timentin; SmithKline Beecham; Treatment for wide range of infections in children, Approved January 1998

Viroptic; King Pharmaceuticals; Treatment for inflammation of the cornea in children due to herpes simplex virus, Approved February 1998

Infections and Infectious Diseases

Allegra-D; Hoechst Marion Roussel; Treatment for nasal congestion due to seasonal allergy, Approved March 1998

Clemastine fumarate syrup; Morton Grove Pharmaceuticals; Generic equivalent of Tavist Syrup, Approved March 1998

REBETRON (TM) Combination Therapy; Schering-Plough; Treatment for Chronic Hepatitis C, Approved June 1998

Synagis; MedImmune; Treatment for the prevention of serious lower respiratory tract disease in infants, Approved June 1998

Viroptic; King Pharmaceuticals; Treatment for inflammation of the cornea in children due to herpes simplex virus, Approved February 1998

Musculoskeletal

Actonel; Procter & Gamble, Hoechst Marion Roussel; Treatment for Paget's Disease, Approved April 1998

Estratab (.3 mg ); Solvay Pharmaceuticals; Treatment for the prevention of osteoporosis, Approved March 1998

Etodolac; Faulding; Generic equivalent of Lodine 500 mg tablets, Approved May 1998

Lodine XL (etodolac); Wyeth; Treatment for arthritis, Approved February 1998

Lovenox (enoxaparin sodium) Injection; Rhone Poulenc Rorer; Treatment for prevention of blood clots following hip-replacement surgery, Approved February 1998

Nephrology

Detrol (tolterodine tartrate); Pharmacia & Upjohn; Treatment for an overactive bladder, Approved March 1998

Ditropan XL (oxybutynin chloride); Alza; Treatment for and Overactive Bladder, Approved December 1998

Proscar; Merck; Treatment for complication relating to benign prostatic hyperplasia (BPH), Approved April 1998

RenaGelRenagel (sevelamer hydrochloride); GelTex Pharmaceuticals; Treatment for Renal Disease, Approved November 1998

Simulect; Novartis; Treatment for acute organ transplant rejection, Approved May 1998

Zemplar; Abbott Laboratories; Treatment of secondary hyperparathyroidism associated with chronic renal failure, Approved April 1998

Neurology

Amerge; GlaxoSmithKline; Treatment for acute migraine, Approved February 1998

Clonazepam; Watson Pharmaceuticals; Generic equivalent of Klonopin, Approved January 1998

Cylert; Abbott Laboratories; Treatment for Attention Deficit Disorder, Approved October 1998

Excedrin Migraine; Bristol-Myers Squibb; Treatment for mild to moderate migraine pain, Approved January 1998

Lamictal Chewable Dispersible Tablets; GlaxoSmithKline; Treatment for Epilepsy, Approved August 1998

Maxalt; Merck; Acute treatment of migraine headache, Approved June 1998

Naltrexone Hydrochloride Tablets; Barr Laboratories; Generic equivalent of Revia, Approved May 1998

Oxycodone and Aspirin; Watson Pharmaceuticals; Generic equivalent of Percodan, Approved March 1998

Tasmar; Roche; Treatment for Parkinson's Disease, Approved January 1998

Obstetrics/Gynecology (Women’s Health)

Cleocin (clindamycin phosphate); Pharmacia & Upjohn; Treatment for bacterial vaginosis, Approved March 1998

Esclim; Fournier Research; Treatment for symptoms associated to Menopause, Approved August 1998

Estratab (.3 mg ); Solvay Pharmaceuticals; Treatment for the prevention of osteoporosis, Approved March 1998

Herceptin; Genentech; Treatment for metastatic breast cancer, Approved October 1998

Inform HER-2/neu breast cancer test; Oncor; Treatment for breast cancer prediction, Approved January 1998

Micardis (telmisartan); Boehringer Ingelheim; Treatment for Hypertension, Approved November 1998

Mircette; Organon; Oral contraceptive, Approved April 1998

Prempro; Wyeth; Treatment for hormone replacement therapy, Approved January 1998

PREVEN ; Emergency Contraceptive Kit; Gynetics; Emergency Contraceptive Pills, Approved September 1998

Prometrium; Schering-Plough; Treatment for Endometrial Hyperplasia, Approved December 1998

Prometrium; Solvay Pharmaceuticals; Treatment for amenorrhea (abnormal cessation of menses), Approved May 1998

Xeloda; Roche; Treatment for advanced breast cancer tumors, Approved April 1998

Oncology

Actiq; Anesta Corporation; Treatment for Cancer Pain, Approved November 1998

Anzemet; Hoechst Marion Roussel; Treatment for the prevention of nausea and vomiting associated with chemotherapy and surgery, Approved February 1998

Camptosar; Pharmacia & Upjohn; Treatment for Colon or Rectal Cancer, Approved October 1998

Gemzar (gemcitabine HCL); Eli Lilly; Treatment for Lung Cancer, Approved August 1998

Herceptin; Genentech; Treatment for metastatic breast cancer, Approved October 1998

Inform HER-2/neu breast cancer test; Oncor; Treatment for breast cancer prediction, Approved January 1998

Neupogen; Amgen; Treatment for slow white blood cell recovery following chemotherapy, Approval April 1998

Nolvadex; AstraZeneca; Treatment for Breast Cancer, Approved October 1998

Photofrin; QLT; Treatment for early-stage, microinvasive endobronchial non-small cell lung cancer, Approved January 1998

Proleukin; Chiron; Treatment for metastatic melanoma, Approved January 1998

Sclerosol Intrapleural Aerosol; Bryan Corporation; Treatment for malignant pleural effusions, Approved January 1998

Valstar; Anthra Pharmaceuticals; Treatment for Bladder Cancer, Approved October 1998

Xeloda; Roche; Treatment for advanced breast cancer tumors, Approved April 1998

Zofran; GlaxoSmithKline; Treatment for postoperative vomiting and nausea in adults, Approved April 1998

Ophthalmology

Alrex; Bausch & Lomb, Pharmos; Treatment for seasonal allergic conjunctivitis, Approved March 1998

Cosopt; Merck; Treatment for glaucoma or ocular hypertension, Approved April 1998

Lotemax; Bausch & Lomb, Pharmos; Treatment for post-operative eye inflammation, Approved March 1998

Salagen Tablets; MGI Pharma; Treatment for Sjogren's Syndrome, Approved February 1998

Viroptic; King Pharmaceuticals; Treatment for inflammation of the cornea in children due to herpes simplex virus, Approved February 1998

Vitravene Injection; Isis Pharmaceuticals; Treatment for CMV in AIDS patients, Approved August 1998

Otolaryngology (Ear, Nose, Throat)

Rocephin; Roche; Treatment for pediatric otitis media, Approved January 1998

Pediatrics/Neonatology

Curosurf; Dey Laboratories; Treatment for respiratory distress syndrome in premature infants., Approved October 1998

Cylert; Abbott Laboratories; Treatment for Attention Deficit Disorder, Approved October 1998

Desmopressin Acetate (DDAVP); Rhone Poulenc Rorer; Treatment for nocturnal enuresis, Approved March 1998

Infasurf; ONY; For the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants, Approved July 1998.

Pulmozyme (dornase alfa); Genentech; Treatment for cystic fibrosis, Approved March 1998

Rocephin; Roche; Treatment for pediatric otitis media, Approved January 1998

Singulair; Merck; Treatment for asthma, Approved February 1998

Timentin; SmithKline Beecham; Treatment for wide range of infections in children, Approved January 1998

Viroptic; King Pharmaceuticals; Treatment for inflammation of the cornea in children due to herpes simplex virus, Approved February 1998

Psychiatry/Psychology

Celexa; Forest Laboratories; Treatment for depression, Approved July 1998

Clomipramine hydrochloride; Mylan Laboratories; Generic equivalent of Anafranil, Approved April 1998

Cylert; Abbott Laboratories; Treatment for Attention Deficit Disorder, Approved October 1998

Marplan Tablets; Roche; Treatment of Depression, Approved August 1998

Naltrexone Hydrochloride Tablets; Barr Laboratories; Generic equivalent of Revia, Approved May 1998

Prochlorperazine; IVAX; Generic equivalent of SmithKline Beecham's Compazine, Approved January 1998

Pulmonary/Respiratory Diseases

Allegra-D; Hoechst Marion Roussel; Treatment for nasal congestion due to seasonal allergy, Approved March 1998

Clemastine fumarate syrup; Morton Grove Pharmaceuticals; Generic equivalent of Tavist Syrup, Approved March 1998

Curosurf; Dey Laboratories; Treatment for respiratory distress syndrome in premature infants., Approved October 1998

Dynabac; Sanofi-aventis; Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections), Approved March 1998

Infasurf; ONY; For the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants, Approved July 1998.

Priftin; Hoechst Marion Roussel; Treatment for pulmonary tuberculosis, Approved June 1998

Pulmozyme (dornase alfa); Genentech; Treatment for cystic fibrosis, Approved March 1998

Sclerosol Intrapleural Aerosol; Bryan Corporation; Treatment for malignant pleural effusions, Approved January 1998

Singulair; Merck; Treatment for asthma, Approved February 1998

Synagis; MedImmune; Treatment for the prevention of serious lower respiratory tract disease in infants, Approved June 1998

Rheumatology

Arava; Hoechst Marion Roussel; Treatment for Rheumatoid Arthritis, Approved September 1998

Lodine XL (etodolac); Wyeth; Treatment for arthritis, Approved February 1998

Salagen Tablets; MGI Pharma; Treatment for Sjogren's Syndrome, Approved February 1998

Urology

Viagra; Pfizer; Treatment for impotence, Approved March 1998